Concepedia

Publication | Closed Access

Low‐dose rituximab every 6 months for the treatment of acetylcholine receptor–positive refractory generalized myasthenia gravis

DOI

31

Citations

18

References

2019

Year

Jun Lü, Huahua Zhong, Sisi Jing, Liang Wang, Jianying Xi, Jiahong Lu, Lei Zhou, Chongbo Zhao
Muscle & Nerve

Abstract

Low-dose rituximab every 6 months is effective in treating refractory GMG patients.

References

YearCitations

Page 1